Business & Regulation

Business & Regulation Profession

Boosting Your Leadership Skills

10/22/2024 | Stephanie Vine

Looking for words of wisdom and tips on being a leader and advancing your career in pharma?

Business & Regulation Trends & Forecasts

Prioritizing Patients and Value

10/18/2024 | 3 min read

What does the future hold for pharma? Audrey Greenberg and Jon Zwinski give their views.

Business & Regulation Trends & Forecasts

Equitable Access to Medicine

10/18/2024

As part of our 10-year anniversary special feature, Markus Kosch tells us his views on the future of pharma.

Business & Regulation Supply Chain

How Do We Make Supply Chains More Resilient?

10/17/2024 | Ronald Kleijwegt | 3 min read

It’s time to go back to basics when it comes to pharmaceutical supply chains and preventing shortages.

Business & Regulation Trends & Forecasts

A Decade of Transformative Treatments

10/11/2024

What trends and disruptions will shape the future of pharma? West’s Anya Harry gives her view.

Business & Regulation Formulation

Compounders Confounded

10/11/2024 | Rob Coker

Why some stakeholders are not happy about the FDA’s removal of tirzepatide from the drug shortage list.

Business & Regulation Trends & Forecasts

Celebrating the final day of CPhI Europe

10/10/2024 | Rob Coker

The highlights of the trade show and its conference agenda - day 3

Business & Regulation Trends & Forecasts

CPhI Europe continues Today in Milan

10/09/2024 | Rob Coker

The highlights of the trade show and its conference agenda - day 2

Business & Regulation Trends & Forecasts

Welcome to CPhI Europe!

10/08/2024 | Rob Coker

The highlights of the trade show and its conference agenda - day 1

Business & Regulation Standards & Regulation

FDA Warning Letters: September 2024 Edition

10/07/2024 | Stephanie Vine | 3 min read

Here’s a look at recent violations cited in FDA Warning Letters: fly pupae, cross contamination, trial dosing errors, and more.

Business & Regulation Trends & Forecasts

Innovate, Collaborate, and Make Medicines Accessible

10/04/2024

Michael Altorfer, CEO, Swiss Biotech Association, gives his view on the future of drug development.

Business & Regulation Trends & Forecasts

The Multifaceted Future of Pharma

10/03/2024 | Stephanie Vine

We asked over 100 industry professionals for their views on the future of the pharma and biopharma industries.

Business & Regulation Business Practice

Driving the Future of Biopharma

10/01/2024 | Rob Coker

Biopharma companies procrastinating on sustainability measures risk falling behind, according to Cytiva’ Global Biopharma Sustainability Review.